Condition: Ischemic Stroke · Oral Anticoagulation · Atrial Fibrillation (AF) · Sponsor: University of L'Aquila
The Advancing knowledge in ischemic Stroke PatiEnts on oRal Anticoagulants (ASPERA) study aims to investigate characteristics of ischemic stroke cases occurring in patients on oral anticoagulation for atrial fibrillation (AF) or other cardioembolic arrhythmias and to characterize short and long-term outcomes associated with different secondary prevention strategies to prevent stroke recurrences. The ASPERA study is a multicenter, observational, both retrospective and prospective real-world study involving acute ischemic stroke patients occurring on oral anticoagulation. The study will encompass a retrospective (ASPERA-R) and prospective (ASPERA-P) data collection. Patient will be recruited consecutively at different emergency services and stroke units worldwide. University of L'Aquila (UnivAQ) will be in charge of study coordination, data analysis and management. The duration of ASPERA-R will be of 5-year from the study initiation of the study. Participating centers will be given a 6-month timeframe to enter retrospective data, commencing from the date of study approval. ASPERA-P duration will be of 2 years of enrollment from the study approval and follow-up of 5 years. (study conclusion after 7 years of approval). Inclusion criteria will be: 1.Confirmed diagnosis of ischemic stroke. 2. Availability of at least one neuroimaging exam positive for ischemic lesion(s) consistent with patient symptoms. 3. Ongoing oral anticoagulation at the time of the index ischemic stroke. 4. P…
This description comes directly from the study's public registry record.
Simona Sacco, MD · +39 0862433561 · simona.sacco@univaq.it
Matteo Foschi, MD · +39 3478929126 · matteo.foschi@graduate.univaq.it
Always discuss trial participation with your own doctor first.
| Department of Neurology, Sveti Duh University Hospital | Zagreb, Croatia | Recruiting |
| Copenhagen University Hospital, Bispebjerg Hospital | Copenhagen, Denmark | Recruiting |
| Neurology Department, Assiut University Hospitals | Asyut, Egypt | Recruiting |
| Neurology Department, Faculty of Medicine , Ain Shams University | Cairo, Egypt | Recruiting |
| Neurology Unit, Kobry Elkoba Medical Complex | Cairo, Egypt | Recruiting |
| Université Cote d'Azur UR2CA-URRIS, Unité Neurovasculaire, CHU Hôpital Pasteur 2 | Nice, France | Recruiting |
| Department of Neurology, Charite, Berlin Germany and Center for Stroke Research (CSB) | Berlin, Germany | Recruiting |
| Department of Neurology, Martin-Luther-University of Halle-Wittenberg | Halle, Germany | Recruiting |
| Neurological Clinic, Marche Polytechnic University | Ancona, Italy | Recruiting |
| SC Neurologia, Stroke Unit, Ospedale di Venere | Bari, Italy | Recruiting |
| IRCCS Istituto delle Scienze Neurologiche | Bologna, Italy | Recruiting |
| SCA Neurologia, USL Umbria 1 | Città di Castello, Italy | Recruiting |
+ 35 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06823466